RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

No RSV vaccine has been approved by the Food and Drug Administration, but the first attempt was made in the 1960s, which was unsuccessful as it led to severe and lethal cases of lung inflammatory ...

The Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory Committee on Immunization Practices’ recommendations for respiratory ...

Supply of RSV antibody shot struggling to meet demand Atlanta — Lucas Cerna's mother is getting him a respiratory syncytial virus shot while his pediatrician still has it in stock.

RSV vaccines will be most effective at saving lives if given before infections climb, which happened unusually early last year. "Lives, hospitalizations, we could have a significant impact this year.

Inpatient mortality and adverse outcomes were significantly more likely among adults hospitalized with RSV infection vs seasonal influenza.

Health experts say the UK should brace for a surge in a potentially serious virus following a record number of cases in ...

For infants born from October to February, maternal vaccination was cost-effective, but compared with vaccination, nirsevimab ...

NHS specialists have called on those eligible for a respiratory syncytial virus (RSV) jab to get vaccinated following a spike ...

Newborn babies whose mother received the RSV vaccination during pregnancy were about 80% less likely to be admitted to ...